FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Paul Zajac

Research Profile

Disorders

Melanoma

Chemicals & Drugs

Anatomy

Living Beings

Vaccinia virus

Procedures

Physiology

Co-author Network

Publications

TOP 3
Nermin Raafat; Charlotte Sadowski-Cron; Giulio C Spagnoli; Michael Heberer; Chantal Mengus; Paul Zajac
Preventing vaccinia virus class-I epitopes presentation by HSV-ICP47 enhances the immunogenicity of a TAP-independent cancer vaccine epitope.
Chitrangada Acharya; Adetola Adesida; Ivan Martin; Marcus Mumme; Jens Riesle; Paul Zajac; Andrea Barbero
Enhanced chondrocyte proliferation and mesenchymal stromal cells chondrogenesis in coculture pellets mediate improved cartilage formation.
Elke Schultz-Thater; Luigi Terracciano; Luigi Tornillo; Paul Zajac; Vincenza Carafa; Giandomenica Iezzi; Clémentine Le Magnen; Salvatore Piscuoglio; Giulio C Spagnoli
MAGE-A10 is a nuclear protein frequently expressed in high percentages of tumor cells in lung, skin and urothelial malignancies.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Paul Zajac (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Nermin Raafat; Charlotte Sadowski-Cron; Giulio C Spagnoli; Michael Heberer; Chantal Mengus; Paul Zajac
Preventing vaccinia virus class-I epitopes presentation by HSV-ICP47 enhances the immunogenicity of a TAP-independent cancer vaccine epitope.
International journal of cancer. Journal international du cancer 2012;131(5):E659-69.
2012: Chitrangada Acharya; Adetola Adesida; Ivan Martin; Marcus Mumme; Jens Riesle; Paul Zajac; Andrea Barbero
Enhanced chondrocyte proliferation and mesenchymal stromal cells chondrogenesis in coculture pellets mediate improved cartilage formation.
Journal of cellular physiology 2012;227(1):88-97.
2011: Elke Schultz-Thater; Luigi Terracciano; Luigi Tornillo; Paul Zajac; Vincenza Carafa; Giandomenica Iezzi; Clémentine Le Magnen; Salvatore Piscuoglio; Giulio C Spagnoli
MAGE-A10 is a nuclear protein frequently expressed in high percentages of tumor cells in lung, skin and urothelial malignancies.
International journal of cancer. Journal international du cancer 2011;129(5):1137-48.
2010: Giulio C Spagnoli; Marzieh Ebrahimi; Giandomenica Iezzi; Chantal Mengus; Paul Zajac
Contemporary immunotherapy of solid tumors: from tumor-associated antigens to combination treatments.
Current opinion in drug discovery & development 2010;13(2):184-92.
2010: Michel Adamina; Rachel Rosenthal; Walter P Weber; Daniel M Frey; Carsten T Viehl; Martin Bolli; Rolf W Huegli; Augustinus L Jacob; Michael Heberer; Daniel Oertli; Walter Marti; Giulio C Spagnoli; Paul Zajac
Intranodal immunization with a vaccinia virus encoding multiple antigenic epitopes and costimulatory molecules in metastatic melanoma.
Molecular therapy : the journal of the American Society of Gene Therapy 2010;18(3):651-9.
2009: Rachel Rosenthal; Célia Groeper; Laura Bracci; Michel Adamina; Chantal Feder-Mengus; Paul Zajac; Giandomenica Iezzi; Martin Bolli; Walter P Weber; Daniel M Frey; Urs von Holzen; Daniel Oertli; Michael Heberer; Giulio C Spagnoli
Differential responsiveness to IL-2, IL-7, and IL-15 common receptor gamma chain cytokines by antigen-specific peripheral blood naive or memory cytotoxic CD8+ T cells from healthy donors and melanoma patients.
Journal of immunotherapy (Hagerstown, Md. : 1997) 2009;32(3):252-61.
2009: Paul Zajac
Non-replicating recombinant vaccinia virus expressing CD80 to enhance T-cell stimulation.
Methods in molecular biology (Clifton, N.J.) 2009;514():151-62.
2008: Laura Bracci; Reto Schumacher; Maurizio Provenzano; Michel Adamina; Rachel Rosenthal; Celia Groeper; Paul Zajac; Giandomenica Iezzi; Enrico Proietti; Filippo Belardelli; Giulio C Spagnoli
Efficient stimulation of T cell responses by human IFN-alpha-induced dendritic cells does not require Toll-like receptor triggering.
Journal of immunotherapy (Hagerstown, Md. : 1997) 2008;31(5):466-74.
2008: Michel Adamina; Walter P Weber; Rachel Rosenthal; Reto Schumacher; Paul Zajac; Ulrich Guller; Daniel M Frey; Daniel Oertli; Markus Zuber; Michael Heberer; Giulio C Spagnoli
Heterologous prime-boost immunotherapy of melanoma patients with Influenza virosomes, and recombinant Vaccinia virus encoding 5 melanoma epitopes and 3 co-stimulatory molecules. A multi-centre phase I/II open labeled clinical trial.
Contemporary clinical trials 2008;29(2):165-81.
2008: Elke Schultz-Thater; Daniel M Frey; Daniela Margelli; Nermin Raafat; Chantal Feder-Mengus; Giulio C Spagnoli; Paul Zajac
Whole blood assessment of antigen specific cellular immune response by real time quantitative PCR: a versatile monitoring and discovery tool.
Journal of translational medicine 2008;6():58.
2007: Chantal Feder-Mengus; Sourabh Ghosh; Walter P Weber; Stephen Wyler; Paul Zajac; Luigi Terracciano; Daniel Oertli; Michael Heberer; Ivan Martin; Giulio C Spagnoli; Anca Reschner
Multiple mechanisms underlie defective recognition of melanoma cells cultured in three-dimensional architectures by antigen-specific cytotoxic T lymphocytes.
British journal of cancer 2007;96(7):1072-82.
2007: Elisabetta Peduzzi; Célia Groeper; Daniela Schütte; Paul Zajac; Simona Rondini; Ernestina Mensah-Quainoo; Giulio C Spagnoli; Gerd Pluschke; Claudia A Daubenberger
Local activation of the innate immune system in Buruli ulcer lesions.
The Journal of investigative dermatology 2007;127(3):638-45.
2007: Célia Groeper; Franco Gambazzi; Paul Zajac; Lukas Bubendorf; Michel Adamina; Rachel Rosenthal; Hans Zerkowski; Michael Heberer; Giulio C Spagnoli
Cancer/testis antigen expression and specific cytotoxic T lymphocyte responses in non small cell lung cancer.
International journal of cancer. Journal international du cancer 2007;120(2):337-43.
2006: Walter P Weber; Chantal Feder-Mengus; Alberto Chiarugi; Rachel Rosenthal; Anca Reschner; Reto Schumacher; Paul Zajac; Heidi Misteli; Daniel M Frey; Daniel Oertli; Michael Heberer; Giulio C Spagnoli
Differential effects of the tryptophan metabolite 3-hydroxyanthranilic acid on the proliferation of human CD8+ T cells induced by TCR triggering or homeostatic cytokines.
European journal of immunology 2006;36(2):296-304.
2006: Maurizio Provenzano; Laura Bracci; Stephen Wyler; Tvrtko Hudolin; Giovanni Sais; Rainer Gosert; Paul Zajac; Giorgio Palu'; Michael Heberer; Hans Hirsch; Giulio C Spagnoli
Characterization of highly frequent epitope-specific CD45RA+/CCR7+/- T lymphocyte responses against p53-binding domains of the human polyomavirus BK large tumor antigen in HLA-A*0201+ BKV-seropositive donors.
Journal of translational medicine 2006;4():47.
2006: Michel Adamina; Reto Schumacher; Paul Zajac; Walter P Weber; Rachel Rosenthal; Célia Groeper; Chantal Feder; Rinaldo Zurbriggen; Mario Amacker; Giulio C Spagnoli; Daniel Oertli; Michael Heberer
Advanced liposomal vectors as cancer vaccines in melanoma immunotherapy.
Journal of liposome research 2006;16(3):195-204.
2005: Sourabh Ghosh; Rachel Rosenthal; Paul Zajac; Walter P Weber; Daniel Oertli; Michael Heberer; Ivan Martin; Giulio C Spagnoli; Anca Reschner
Culture of melanoma cells in 3-dimensional architectures results in impaired immunorecognition by cytotoxic T lymphocytes specific for Melan-A/MART-1 tumor-associated antigen.
Annals of surgery 2005;242(6):851-7, discussion 858.
2005: Michel Adamina; Silvia Daetwiler; Rachel Rosenthal; Paul Zajac
Clinical applications of recombinant virus-based cancer immunotherapy.
Expert opinion on biological therapy 2005;5(9):1211-24.
2005: Martin Bolli; Elke Schultz-Thater; Paul Zajac; Ulrich Guller; Chantal Feder; Francesca Sanguedolce; Vincenza Carafa; Luigi Terracciano; Tvrtko Hudolin; Giulio C Spagnoli; Luigi Tornillo
NY-ESO-1/LAGE-1 coexpression with MAGE-A cancer/testis antigens: a tissue microarray study.
International journal of cancer. Journal international du cancer 2005;115(6):960-6.
2005: Urs von Holzen; Michel Adamina; Martin Bolli; Walter P Weber; Paul Zajac; Célia Groeper; Anca Reschner; Chantal Feder; Reto Schumacher; Walter R Marti; Daniel Oertli; Michael Heberer; Giulio C Spagnoli
Selective responsiveness to common gamma chain cytokines in peripheral blood-derived cytotoxic T lymphocytes induced by Melan-A/MART-1(27-35)targeted active specific immunotherapy.
International journal of cancer. Journal international du cancer 2005;115(2):248-55.
2005: Giulio C Spagnoli; Michel Adamina; Martin Bolli; Walter P Weber; Paul Zajac; Walter R Marti; Daniel Oertli; Michael Heberer; Felix Harder
Active antigen-specific immunotherapy of melanoma: from basic science to clinical investigation.
World journal of surgery 2005;29(6):692-9.
2005: Chantal Feder-Mengus; Elke Schultz-Thater; Daniel Oertli; Walter R Marti; Michael Heberer; Giulio C Spagnoli; Paul Zajac
Nonreplicating recombinant vaccinia virus expressing CD40 ligand enhances APC capacity to stimulate specific CD4+ and CD8+ T cell responses.
Human gene therapy 2005;16(3):348-60.
2004: Reto Schumacher; Michel Adamina; Rinaldo Zurbriggen; Martin Bolli; Elisabetta Padovan; Paul Zajac; Michael Heberer; Giulio C Spagnoli
Influenza virosomes enhance class I restricted CTL induction through CD4+ T cell activation.
Vaccine 2004;22(5-6):714-23.
2004: Michel Adamina; Martin Bolli; Federica Albo; A Cavazza; Paul Zajac; Elisabetta Padovan; Reto Schumacher; Anca Reschner; Chantal Feder; Walter R Marti; Daniel Oertli; Michael Heberer; Giulio C Spagnoli
Encapsulation into sterically stabilised liposomes enhances the immunogenicity of melanoma-associated Melan-A/MART-1 epitopes.
British journal of cancer 2004;90(1):263-9.
2003: Paul Zajac; Daniel Oertli; Walter R Marti; Michel Adamina; Martin Bolli; U Guller; Christoph Noppen; Elisabetta Padovan; Elke Schultz-Thater; Michael Heberer; Giulio Spagnoli
Phase I/II clinical trial of a nonreplicative vaccinia virus expressing multiple HLA-A0201-restricted tumor-associated epitopes and costimulatory molecules in metastatic melanoma patients.
Human gene therapy 2003;14(16):1497-510.
2002: Ulrich Guller; Paul Zajac; Annelies Schnider; Beatrix Bösch; Stefan Vorburger; Markus Zuber; Giulio C Spagnoli; Daniel Oertli; Robert Maurer; Urs Metzger; Felix Harder; Michael Heberer; Walter R Marti
Disseminated single tumor cells as detected by real-time quantitative polymerase chain reaction represent a prognostic factor in patients undergoing surgery for colorectal cancer.
Annals of surgery 2002;236(6):768-75; discussion 775-6.
2002: Peter Jantscheff; Giulio Spagnoli; Paul Zajac; Christoph Rochlitz
Cell fusion: an approach to generating constitutively proliferating human tumor antigen-presenting cells.
Cancer immunology, immunotherapy : CII 2002;51(7):367-75.
2002: Daniel Oertli; Walter R Marti; Paul Zajac; Christoph Noppen; Thomas Kocher; Elisabetta Padovan; Michel Adamina; Reto Schumacher; Felix Harder; Michael Heberer; Giulio C Spagnoli
Rapid induction of specific cytotoxic T lymphocytes against melanoma-associated antigens by a recombinant vaccinia virus vector expressing multiple immunodominant epitopes and costimulatory molecules in vivo.
Human gene therapy 2002;13(4):569-75.
2002: Giulio C Spagnoli; Paul Zajac; Walter R Marti; Daniel Oertli; Elisabetta Padovan; Christoph Noppen; Thomas Kocher; Michel Adamina; Michael Heberer
Cytotoxic T-cell induction in metastatic melanoma patients undergoing recombinant vaccinia virus-based immuno-gene therapy.
Recent results in cancer research. Fortschritte der Krebsforschung. Progrès dans les recherches sur le cancer 2002;160():195-201.
2001: A Schütz; Daniel Oertli; Walter R Marti; Christoph Noppen; Elisabetta Padovan; Giulio C Spagnoli; Michael Heberer; Paul Zajac
Immunogenicity of nonreplicating recombinant vaccinia expressing HLA-A201 targeted or complete MART-1/Melan-A antigen.
Cancer gene therapy 2001;8(9):655-61.
2001: Eugenia Remmel; Luigi Terracciano; Christoph Noppen; Paul Zajac; Michael Heberer; Giulio C Spagnoli; Elisabetta Padovan
Modulation of dendritic cell phenotype and mobility by tumor cells in vitro.
Human immunology 2001;62(1):39-49.
2000: Christoph Noppen; Frédéric Lévy; Lena Burri; Paul Zajac; Eugenia Remmel; C Schaefer; U Lüscher; Michael Heberer; Giulio C Spagnoli
Naturally processed and concealed HLA-A2.1-restricted epitopes from tumor-associated antigen tyrosinase-related protein-2.
International journal of cancer. Journal international du cancer 2000;87(2):241-6.
2000: Elke Schultz-Thater; Christoph Noppen; Fred Gudat; Ursula Dürmüller; Paul Zajac; Thomas Kocher; Michael Heberer; Giulio C Spagnoli
NY-ESO-1 tumour associated antigen is a cytoplasmic protein detectable by specific monoclonal antibodies in cell lines and clinical specimens.
British journal of cancer 2000;83(2):204-8.
2000: Giulio C Spagnoli; J Kloth; Luigi Terracciano; M Trutmann; E Chklovskaia; Eugenia Remmel; Christoph Noppen; Paul Zajac; Thomas Kocher; Michael Heberer
FLT3 ligand gene expression and protein production in human colorectal cancer cell lines and clinical tumor specimens.
International journal of cancer. Journal international du cancer 2000;86(2):238-43.
2000: Danila Valmori; Frédéric Lévy; Isabelle Miconnet; Paul Zajac; Giulio C Spagnoli; Donata Rimoldi; Danielle Liénard; Vincenzo Cerundolo; Jean-Charles Cerottini; Pedro Romero
Induction of potent antitumor CTL responses by recombinant vaccinia encoding a melan-A peptide analogue.
Journal of immunology (Baltimore, Md. : 1950) 2000;164(2):1125-31.
1998: Paul Zajac; A Schütz; Daniel Oertli; Christoph Noppen; C Schaefer; Michael Heberer; Giulio C Spagnoli; Walter R Marti
Enhanced generation of cytotoxic T lymphocytes using recombinant vaccinia virus expressing human tumor-associated antigens and B7 costimulatory molecules.
Cancer research 1998;58(20):4567-71.
1998: M Trutmann; Luigi Terracciano; Christoph Noppen; J Kloth; M Kaspar; Ralph Peterli; Peter Tondelli; C Schaeffer; Paul Zajac; Michael Heberer; Giulio C Spagnoli
GM-CSF gene expression and protein production in human colorectal cancer cell lines and clinical tumor specimens.
International journal of cancer. Journal international du cancer 1998;77(3):378-85.
1998: Christoph Noppen; C Schaefer; Paul Zajac; A Schütz; Thomas Kocher; J Kloth; Michael Heberer; Marco COLONna; Gennaro De Libero; Giulio C Spagnoli
C-type lectin-like receptors in peptide-specific HLA class I-restricted cytotoxic T lymphocytes: differential expression and modulation of effector functions in clones sharing identical TCR structure and epitope specificity.
European journal of immunology 1998;28(4):1134-42.
1998: Walter R Marti; A Schütz; Daniel Oertli; Paul Zajac; Felix Harder; M Heberer
[Recombinant vaccinia viruses as efficient vectors of biologically active, human B7 costimulation molecules].
Langenbecks Archiv für Chirurgie. Supplement. Kongressband. Deutsche Gesellschaft für Chirurgie. Kongress 1998;115(Suppl I):131-6.
1998: A Schütz; Walter R Marti; Paul Zajac; Daniel Oertli; F Harder; M Heberer
[B7 costimulation molecules improve induction of tumor specific cytotoxic T-cells against MART-1(27-35)].
Langenbecks Archiv für Chirurgie. Supplement. Kongressband. Deutsche Gesellschaft für Chirurgie. Kongress 1998;115(Suppl I):125-9.
1997: Walter R Marti; Paul Zajac; Giulio Spagnoli; Michael Heberer; Daniel Oertli
Nonreplicating recombinant vaccinia virus encoding human B-7 molecules elicits effective costimulation of naive and memory CD4+ T lymphocytes in vitro.
Cellular immunology 1997;179(2):146-52.
1997: C Fischer; Fred Gudat; P Stulz; Christoph Noppen; C Schaefer; Paul Zajac; M Trutmann; Thomas Kocher; M Zuber; F Harder; Michael Heberer; Giulio C Spagnoli
High expression of MAGE-3 protein in squamous-cell lung carcinoma.
International journal of cancer. Journal international du cancer 1997;71(6):1119-21.
1997: Paul Zajac; Daniel Oertli; Giulio C Spagnoli; Christoph Noppen; C Schaefer; Michael Heberer; Walter R Marti
Generation of tumoricidal cytotoxic T lymphocytes from healthy donors after in vitro stimulation with a replication-incompetent vaccinia virus encoding MART-1/Melan-A 27-35 epitope.
International journal of cancer. Journal international du cancer 1997;71(3):491-6.